Logo image of INVX

INNOVEX INTERNATIONAL INC (INVX) Stock Fundamental Analysis

NYSE:INVX - New York Stock Exchange, Inc. - US4576511079 - Common Stock - Currency: USD

16.14  -0.43 (-2.6%)

Premarket: 18 +1.86 (+11.52%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to INVX. INVX was compared to 59 industry peers in the Energy Equipment & Services industry. INVX has a great financial health rating, but its profitability evaluates not so good. INVX has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year INVX has reported negative net income.
INVX had a positive operating cash flow in the past year.
In multiple years INVX reported negative net income over the last 5 years.
In multiple years INVX reported negative operating cash flow during the last 5 years.
INVX Yearly Net Income VS EBIT VS OCF VS FCFINVX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M -100M 200M

1.2 Ratios

INVX has a Return On Assets of 7.98%. This is in the better half of the industry: INVX outperforms 72.41% of its industry peers.
INVX has a Return On Equity of 10.00%. This is comparable to the rest of the industry: INVX outperforms 58.62% of its industry peers.
With a Return On Invested Capital value of 4.92%, INVX perfoms like the industry average, outperforming 41.38% of the companies in the same industry.
Industry RankSector Rank
ROA 7.98%
ROE 10%
ROIC 4.92%
ROA(3y)-4.28%
ROA(5y)-3.07%
ROE(3y)-4.81%
ROE(5y)-3.45%
ROIC(3y)N/A
ROIC(5y)N/A
INVX Yearly ROA, ROE, ROICINVX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5 -5 10 -10

1.3 Margins

INVX has a better Profit Margin (13.98%) than 86.21% of its industry peers.
With a Operating Margin value of 9.22%, INVX perfoms like the industry average, outperforming 51.72% of the companies in the same industry.
The Gross Margin of INVX (33.13%) is better than 63.79% of its industry peers.
In the last couple of years the Gross Margin of INVX has declined.
Industry RankSector Rank
OM 9.22%
PM (TTM) 13.98%
GM 33.13%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.44%
GM growth 5Y-1.51%
INVX Yearly Profit, Operating, Gross MarginsINVX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so INVX is destroying value.
The number of shares outstanding for INVX has been increased compared to 1 year ago.
The number of shares outstanding for INVX has been reduced compared to 5 years ago.
INVX has a worse debt/assets ratio than last year.
INVX Yearly Shares OutstandingINVX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M
INVX Yearly Total Debt VS Total AssetsINVX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B

2.2 Solvency

INVX has an Altman-Z score of 4.43. This indicates that INVX is financially healthy and has little risk of bankruptcy at the moment.
INVX's Altman-Z score of 4.43 is amongst the best of the industry. INVX outperforms 91.38% of its industry peers.
INVX has a debt to FCF ratio of 0.35. This is a very positive value and a sign of high solvency as it would only need 0.35 years to pay back of all of its debts.
INVX has a better Debt to FCF ratio (0.35) than 94.83% of its industry peers.
INVX has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.01, INVX belongs to the top of the industry, outperforming 91.38% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.35
Altman-Z 4.43
ROIC/WACC0.54
WACC9.18%
INVX Yearly LT Debt VS Equity VS FCFINVX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500M 1B

2.3 Liquidity

A Current Ratio of 3.87 indicates that INVX has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 3.87, INVX belongs to the top of the industry, outperforming 91.38% of the companies in the same industry.
INVX has a Quick Ratio of 2.17. This indicates that INVX is financially healthy and has no problem in meeting its short term obligations.
INVX has a Quick ratio of 2.17. This is in the better half of the industry: INVX outperforms 79.31% of its industry peers.
Industry RankSector Rank
Current Ratio 3.87
Quick Ratio 2.17
INVX Yearly Current Assets VS Current LiabilitesINVX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B

5

3. Growth

3.1 Past

The earnings per share for INVX have decreased strongly by -400.00% in the last year.
The Revenue has grown by 63.93% in the past year. This is a very strong growth!
INVX shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.97% yearly.
EPS 1Y (TTM)-400%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-13.33%
Revenue 1Y (TTM)63.93%
Revenue growth 3Y5.13%
Revenue growth 5Y1.97%
Sales Q2Q%29.49%

3.2 Future

Based on estimates for the next years, INVX will show a very strong growth in Earnings Per Share. The EPS will grow by 119.45% on average per year.
The Revenue is expected to grow by 9.80% on average over the next years. This is quite good.
EPS Next Y868.4%
EPS Next 2Y210.1%
EPS Next 3Y119.45%
EPS Next 5YN/A
Revenue Next Year14.63%
Revenue Next 2Y11.67%
Revenue Next 3Y9.8%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
INVX Yearly Revenue VS EstimatesINVX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M 800M
INVX Yearly EPS VS EstimatesINVX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 2 4

4

4. Valuation

4.1 Price/Earnings Ratio

INVX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 14.13, the valuation of INVX can be described as correct.
Compared to the rest of the industry, the Price/Forward Earnings ratio of INVX is on the same level as its industry peers.
The average S&P500 Price/Forward Earnings ratio is at 22.65. INVX is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 14.13
INVX Price Earnings VS Forward Price EarningsINVX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of INVX indicates a rather expensive valuation: INVX more expensive than 82.76% of the companies listed in the same industry.
The rest of the industry has a similar Price/Free Cash Flow ratio as INVX.
Industry RankSector Rank
P/FCF 17
EV/EBITDA 11.91
INVX Per share dataINVX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

INVX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as INVX's earnings are expected to grow with 119.45% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y210.1%
EPS Next 3Y119.45%

0

5. Dividend

5.1 Amount

INVX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

INNOVEX INTERNATIONAL INC

NYSE:INVX (2/25/2025, 8:04:01 PM)

Premarket: 18 +1.86 (+11.52%)

16.14

-0.43 (-2.6%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryEnergy Equipment & Services
Earnings (Last)11-07 2024-11-07/amc
Earnings (Next)N/A N/A
Inst Owners47.97%
Inst Owner Change-88.63%
Ins Owners1.52%
Ins Owner Change81.93%
Market Cap1.12B
Analysts40
Price Target15.3 (-5.2%)
Short Float %N/A
Short Ratio4.22
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-110.4%
Min EPS beat(2)-165.36%
Max EPS beat(2)-55.44%
EPS beat(4)0
Avg EPS beat(4)-270.41%
Min EPS beat(4)-782.97%
Max EPS beat(4)-55.44%
EPS beat(8)1
Avg EPS beat(8)-160.35%
EPS beat(12)2
Avg EPS beat(12)-107.94%
EPS beat(16)2
Avg EPS beat(16)-662.7%
Revenue beat(2)1
Avg Revenue beat(2)3.88%
Min Revenue beat(2)-2.49%
Max Revenue beat(2)10.25%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-34.78%
EPS NQ rev (1m)-14.81%
EPS NQ rev (3m)-9.8%
EPS NY rev (1m)-63.67%
EPS NY rev (3m)769.23%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-4.97%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 14.13
P/S 1.73
P/FCF 17
P/OCF 13.41
P/B 1.23
P/tB 1.32
EV/EBITDA 11.91
EPS(TTM)-0.65
EYN/A
EPS(NY)1.14
Fwd EY7.08%
FCF(TTM)0.95
FCFY5.88%
OCF(TTM)1.2
OCFY7.46%
SpS9.35
BVpS13.08
TBVpS12.21
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 7.98%
ROE 10%
ROCE 6.23%
ROIC 4.92%
ROICexc 5.49%
ROICexgc 5.9%
OM 9.22%
PM (TTM) 13.98%
GM 33.13%
FCFM 10.15%
ROA(3y)-4.28%
ROA(5y)-3.07%
ROE(3y)-4.81%
ROE(5y)-3.45%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.44%
GM growth 5Y-1.51%
F-Score5
Asset Turnover0.57
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.35
Debt/EBITDA 0.14
Cap/Depr 63.47%
Cap/Sales 2.71%
Interest Coverage 250
Cash Conversion 95.34%
Profit Quality 72.65%
Current Ratio 3.87
Quick Ratio 2.17
Altman-Z 4.43
F-Score5
WACC9.18%
ROIC/WACC0.54
Cap/Depr(3y)68.2%
Cap/Depr(5y)55.03%
Cap/Sales(3y)5.33%
Cap/Sales(5y)4.41%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-400%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-13.33%
EPS Next Y868.4%
EPS Next 2Y210.1%
EPS Next 3Y119.45%
EPS Next 5YN/A
Revenue 1Y (TTM)63.93%
Revenue growth 3Y5.13%
Revenue growth 5Y1.97%
Sales Q2Q%29.49%
Revenue Next Year14.63%
Revenue Next 2Y11.67%
Revenue Next 3Y9.8%
Revenue Next 5YN/A
EBIT growth 1Y6554.22%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year742.86%
EBIT Next 3Y135.99%
EBIT Next 5YN/A
FCF growth 1Y317.09%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y674.88%
OCF growth 3YN/A
OCF growth 5Y-29.85%